Using Quantitative Systems Toxicology (QST) to Assess Drug Safety: The Experience of the DILIsimInitiative. ®

Authors: Watkins PB
Conference: CRS
Software: DILIsym®
Division: DILIsym Services

Drug-Induced Liver Injury (DILI)
1). Remains a major problem in drug development
2). The DILIsim Initiative is a public private partnership developing software capable to explaining and predicting DILI liability in new drug candidates.

Controlled Release Society Annual Meeting & Exposition, July 16-19, 2017, Boston, MA

By Paul B Watkins